Voyager Therapeutics (VYGR) Receives a Buy from Truist Financial
In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Voyager Therapeutics (VYGR – Research Report). The ...
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance
The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic Inflation Reduction Act (“IRA”). With Donald Trump’s reelection, the ...
Business Insider3d
Intellia Therapeutics (NTLA) Gets a Buy from Truist Financial
The company’s shares opened today at $17.38. Lee covers the Healthcare sector, focusing on stocks such as Argenx Se, Corcept Therapeutics, and Viking Therapeutics. According to TipRanks, Lee has an ...
Zacks.com on MSN6dOpinion
5 Small Drug Stocks to Buy as Trump Gets Re-Elected
The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic ...